Simulations that capture antigen–antibody complexity
Crossref DOI link: https://doi.org/10.1038/s43588-022-00379-x
Published Online: 2022-12-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Meysman, Pieter http://orcid.org/0000-0001-5903-633X
Text and Data Mining valid from 2022-12-19
Version of Record valid from 2022-12-19
Article History
First Online: 19 December 2022
Competing interests
: P.M. holds shares in ImmuneWatch BV, an immunoinformatics company.